- Home
- PRSU vs NEO Comparison
PRSU vs NEO Comparison
Compare PRSU & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSU
- NEO
- Stock Information
- Founded
- PRSU 1926
- NEO 2001
- Country
- PRSU United States
- NEO United States
- Employees
- PRSU N/A
- NEO N/A
- Industry
- PRSU Business Services
- NEO Precision Instruments
- Sector
- PRSU Consumer Discretionary
- NEO Health Care
- Exchange
- PRSU Nasdaq
- NEO Nasdaq
- Market Cap
- PRSU 999.2M
- NEO 1.0B
- IPO Year
- PRSU N/A
- NEO 1999
- Fundamental
- Price
- PRSU $37.49
- NEO $8.34
- Analyst Decision
- PRSU Strong Buy
- NEO Buy
- Analyst Count
- PRSU 3
- NEO 9
- Target Price
- PRSU $29.67
- NEO $12.63
- AVG Volume (30 Days)
- PRSU 206.8K
- NEO 2.7M
- Earning Date
- PRSU 08-06-2025
- NEO 11-04-2025
- Dividend Yield
- PRSU N/A
- NEO N/A
- EPS Growth
- PRSU 1138.43
- NEO N/A
- EPS
- PRSU 9.98
- NEO N/A
- Revenue
- PRSU $382,378,000.00
- NEO $689,189,000.00
- Revenue This Year
- PRSU $22.00
- NEO $10.40
- Revenue Next Year
- PRSU $8.35
- NEO $10.11
- P/E Ratio
- PRSU $4.15
- NEO N/A
- Revenue Growth
- PRSU 4.63
- NEO 9.70
- 52 Week Low
- PRSU $26.66
- NEO $4.72
- 52 Week High
- PRSU $47.49
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- PRSU 64.92
- NEO 64.46
- Support Level
- PRSU $35.74
- NEO $7.36
- Resistance Level
- PRSU $38.13
- NEO $8.29
- Average True Range (ATR)
- PRSU 0.91
- NEO 0.45
- MACD
- PRSU -0.21
- NEO 0.06
- Stochastic Oscillator
- PRSU 70.40
- NEO 74.47
About PRSU Pursuit Attractions and Hospitality Inc. Common Stock
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.